Test name | Normal ranges |
---|---|
CRP (mg/dL) | ≤0.30 |
Hemoglobin (g/dL) | Male: 13.5-17.5 Female: 11.5-15.0 |
Platelet count (104/μL) | 14.0-34.0 |
Leukocyte count (/μL) | 3,300-9,000 |
Abnormal cells | Presence of immature blast cells, multiple atypical cells, or more than 30 erythroblasts in 200 nucleated cells |
Blood sugar (mg/dL) | 70-109 |
AST (GOT) (IU/L) | 10-40 |
ALT (GPT) (IU/L) | 5-45 |
Creatinine (mg/dL) | Male: 0.61-1.04 Female: 0.47-0.79 |
Blood urea nitrogen (mg/dL) | 8.0-20.0 |
Uric acid (mg/dL) | Male: 3.8-7.0 Female: 2.5-7.0 |
Serum Na (mEq/L) | 137-147 |
Renal dysfunction | Lipid abnormality | Hematological abnormality | Liver dysfunction | ||||||
---|---|---|---|---|---|---|---|---|---|
+ | - | + | - | + | - | + | - | ||
Abnormal Blood sugar | + (n = 118) | 51 | 67 | 85 | 33 | 17 | 101 | 18 | 100 |
- (n = 136) | 50 | 86 | 5 | 131 | 25 | 111 | 10 | 126 | |
p-value | 0.35761 | <0.00012 | 0.49571 | 0.071151 | |||||
Renal dysfunction | + (n = 101) | 40 | 61 | 19 | 82 | 12 | 89 | ||
- (n = 153) | 50 | 103 | 23 | 130 | 16 | 137 | |||
p-value | 0.31971 | 0.53471 | 0.88091 | ||||||
Lipid abnormality | + (n = 90) | 11 | 79 | 13 | 77 | ||||
- (n = 164) | 31 | 133 | 15 | 149 | |||||
p-value | 0.23241 | 0.28011 | |||||||
Hematological abnormality | + (n = 42) | 3 | 39 | ||||||
- (n = 212) | 25 | 187 | |||||||
p-value | 0.58892 | ||||||||
Liver dysfunction | + (n = 28) | ||||||||
- (n = 226) | |||||||||
p-value |
Response to the questionnaire of all the participants1 | No answer nor response |
Total | |||||
---|---|---|---|---|---|---|---|
Under regular treatment | Discontinuation of follow-up | Lifestyle precaution | Doctor’s follow-up w/o medication | Never being pointed out | |||
Presurvey (n = 228) |
95 (41.7%)2 |
15 (6.6%) |
39 (17.1%) |
24 (10.5%) |
55 (24.1%) |
26 | 254 |
Posturgent notification (n = 163) |
116 (71.2%) |
3 (1.8%) |
21 (12.9%) |
8 (4.9%) |
15 (9.2%) |
91 | |
Participants who responded to both questionnaires3 | |||||||
Presurvey (n = 151) |
68 (45.0%)4 |
7 (4.6%) |
25 (16.6%) |
14 (9.3%) |
37 (24.5%) |
NA5 | 151 |
Posturgent notification (n = 151) |
107 (70.9%) |
3 (2.0%) |
20 (13.2%) |
8 (5.3%) |
13 (8.6%) |